ARCHIVES

Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

ORI Clears Los Angeles Physician Of Misconduct In NSABP Participation

June 16, 1995

FOLFOX4 Improved PFS In Colorectal Cancer

April 25, 2008

In Congress: Senate Resolution Includes $15 Billion For NIH In FY99

April 10, 1998

NCI Natural Product Drug Development To Get New Emphasis; Suggestions Of Critic Accepted

March 19, 1976

NCAB Needs Focus, Strong Membership To Better Advise NCI, Chairman Rimer Says

September 22, 1995

North Central Group Review Postponed While New Committee Formed To Handle All “Regional: Groups

July 10, 1981